No movement on pharmacare calls Liberal-NDP deal into question

Without pharmacare, Justin Trudeau cannot claim to have delivered transformative change in Canada’s health-care system, and Jagmeet Singh cannot claim to have used his leverage through the confidence-and-supply deal to move forward on a progressive health-care agenda for Canadians.

NDP Leader Jagmeet Singh, left, shakes hands with Prime Minister Justin Trudeau in 2019. The fate of pharmacare in Canada—and the Liberal-NDP agreement—can be decided by the prime minister's ability to put daylight between his government and the powerful pharmaceutical and insurance industries, write Dr. Danielle Martin and Nik Barry-Shaw.The Hill Times photograph by Andrew Meade

Opinion

BY Danielle Martin,Nik Barry-Shaw

April 12, 2023

One year into the confidence-and-supply agreement, and with a new federal budget on the table, there is still no movement on the long-promised pharmacare program. Despite the fact that

To keep reading, subscribe and become a political insider.

Only $7.76 a week for an annual subscription.

Enjoy unlimited website access and the digital newspaper.

Cancel anytime.

Already a Subscriber?

Get Weekend Point of View Newsletter

A round up of the past weekâ€™s opinion writers and columnists on Saturdays and Sundays.

By entering your email address you consent to receive email from The Hill Times containing news, analysis, updates and offers. You may unsubscribe at any time. See our privacy policy